Hillrom acquires EarlySense’s contact-free continuous monitoring technology
EarlySense's contact-free continuous monitoring technology has been integrated into Hillrom's Centrella Smart+ med-surg bed
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
EarlySense's contact-free continuous monitoring technology has been integrated into Hillrom's Centrella Smart+ med-surg bed
Hepatic uses non-invasive quantitative multiparametric MRI to provide a liver health assessment
The bioresorbable 3D printed cage enables to prevent leg amputations in patients with severe lower leg fractures
The rapid test device is now allowed for asymptomatic testing and self-swabbing use in Europe
The novel swab is said to provide a sample concentration of up to 30 fold over other swabs…
The UBI SARS-CoV-2 test holds the potential to detect individuals with an adaptive immune response to SARS-CoV-2
The deal enables to combine numares’ expertise in leveraging metabolomics for software-based diagnostics with Bruker’s NMR technology
SENSEI, which is claimed to be the world’s first approved robotic gamma probe, facilitates sentinel lymph node detection
The acquisition is expected to complement Hillrom's current cardiology portfolio of cardiac stress exercise, Holter and resting ECG…
The new service, which will utilise Guardant Health’s advanced digital sequencing platform, will be established at VHIO’s facility…